Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Rheumatology

Does Lupus Increase Your Risk of Heart Disease?

At a Glance

Yes, systemic lupus erythematosus (SLE) significantly increases the risk of cardiovascular disease due to chronic inflammation, kidney involvement, and steroid use. However, taking hydroxychloroquine, monitoring blood pressure, and living a heart-healthy lifestyle can help protect your heart.

Yes, systemic lupus erythematosus (SLE) significantly increases the risk of developing cardiovascular disease. People with lupus have a risk of heart disease and events like heart attacks that can be up to 10 times higher than that of the general population [1][2].

While that statistic sounds frightening, it is important to understand the context. This “relative risk” is highest in young women with lupus compared to healthy women of the exact same age (who naturally have an extremely low baseline risk of heart attacks). So, while your absolute risk right now might still be small, it is elevated enough that your rheumatologist will monitor your blood pressure, cholesterol, and overall heart health very closely.

The “Bimodal” Risk of Lupus

Doctors often describe the timeline of lupus risks as having a “bimodal” pattern—meaning the major health risks peak at two different stages of the disease.

Early in your diagnosis, the primary focus is on controlling the lupus itself. During this first stage, the greatest risks come from active flares (periods of intense disease activity) and potential infections [3]. However, as time goes on and treatments help stabilize the immune system, the focus shifts. Years later, cardiovascular disease emerges as one of the leading long-term health concerns [3]. Understanding this shift helps explain why your care team is already thinking about your heart, even if your immediate concern is joint pain or fatigue.

Why Does Lupus Affect the Heart and Arteries?

The connection between lupus and cardiovascular disease primarily comes down to the disease’s effects on your organs and blood vessels, as well as the impact of certain medications.

  • Chronic Inflammation: Lupus causes your immune system to mistakenly attack your own tissues, creating ongoing, system-wide inflammation. Over time, this constant inflammation damages the delicate inner lining of your blood vessels [4]. This vascular injury accelerates atherosclerosis—a buildup of fatty plaques that stiffen and narrow the arteries—causing it to develop much earlier and progress faster than it would in someone without lupus [5][6].
  • Lupus Nephritis (Kidney Involvement): If lupus attacks your kidneys, it can severely impact your blood pressure and cholesterol levels, acting as a major secondary driver of cardiovascular risk [7].
  • Corticosteroids: Medications like prednisone are often essential and life-saving for controlling severe lupus flares. However, long-term or high-dose use of these steroids can contribute to weight gain, raise your blood pressure, increase your blood sugar, and alter your cholesterol levels [8][9].
  • Antiphospholipid Antibodies: Some people with lupus have immune proteins that mistakenly attack normal proteins in the blood. This significantly increases the risk of blood clots and further raises cardiovascular risk [10].

The Good News: Cardioprotective Medications
Not all lupus treatments harm your heart. In fact, hydroxychloroquine (Plaquenil)—the foundational medication for most lupus patients—is widely recognized for its heart-protective benefits. Long-term use of hydroxychloroquine helps lower cholesterol levels, reduces the risk of blood clots, and protects against the progression of plaque in your arteries [11][12][13].

Recognizing the Warning Signs

Because 90% of lupus patients are women, it is crucial to recognize that heart attacks often do not present as the classic “crushing chest pain.” While chest pain can happen, women frequently experience “atypical” symptoms, including:

  • Profound, unexplained fatigue
  • Shortness of breath
  • Nausea or vomiting
  • Pain in the back, neck, jaw, or stomach

Note: Many lupus patients experience chest pain from pleurisy (inflammation of the lung lining) or costochondritis (inflammation of the rib cartilage). Pleurisy pain typically sharpens when you take a deep breath. However, never ignore new or worsening chest pain—always seek emergency medical care to rule out a heart event.

The Importance of Monitoring

Because lupus itself places a heavy burden on your cardiovascular system, you and your doctor have less “wiggle room” when it comes to standard heart risks [14]. Your medical team must aggressively control anything else that could stress your heart [15].

  • Blood Pressure: Hypertension (high blood pressure) forces your heart to work harder and puts extra mechanical stress on inflamed blood vessels.
  • Cholesterol: Dyslipidemia (abnormal levels of fats in the blood, such as high “bad” LDL cholesterol or low “good” HDL cholesterol) provides the raw materials that form artery-clogging plaques [16].

Taking Charge of Your Heart Health

While lupus is a lifelong condition, you have a lot of power to protect your heart. Controlling traditional cardiovascular risk factors is one of the most effective ways to offset the risks introduced by lupus.

  • Maintain your foundational medications: Take medications like hydroxychloroquine exactly as prescribed, as they actively protect your heart and blood vessels [13].
  • Keep up with your labs: Ensure your cholesterol, blood sugar, and kidney function are checked regularly.
  • Monitor your blood pressure: Have it checked at every doctor’s visit, and consider checking it periodically at home.
  • Work on tapering steroids: Work closely with your rheumatologist to find the lowest effective dose of corticosteroids, or discuss steroid-sparing medications to control your disease [8].
  • Adopt a heart-healthy lifestyle: Focus on an anti-inflammatory or heart-healthy diet (like the Mediterranean diet), stay as physically active as your body allows, and absolutely avoid smoking, which multiplies the damage to your blood vessels.

Common questions in this guide

Why does systemic lupus erythematosus increase heart disease risk?
Lupus causes chronic inflammation that damages the inner lining of blood vessels, accelerating the buildup of fatty plaques. Additionally, complications like lupus nephritis and the long-term use of corticosteroids can further raise blood pressure and cholesterol.
Do my lupus medications harm my heart?
While long-term use of high-dose corticosteroids can increase heart risks, other lupus medications are highly protective. Hydroxychloroquine, for example, actively protects your heart by lowering cholesterol and reducing the risk of blood clots.
What are the warning signs of a heart attack for women with lupus?
Women often do not experience classic crushing chest pain during a heart event. Instead, you may feel profound unexplained fatigue, shortness of breath, nausea, vomiting, or pain radiating to the back, neck, jaw, or stomach.
How can I protect my heart if I have lupus?
You can offset your risk by taking foundational medications like hydroxychloroquine, working with your doctor to safely taper corticosteroids, and strictly controlling your blood pressure and cholesterol. A heart-healthy diet and avoiding smoking are also crucial.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is my current cardiovascular risk, and how often should we check my blood pressure and cholesterol?
  2. 2.Should I be evaluated by a preventive cardiologist given my lupus diagnosis?
  3. 3.How does my current daily dose of steroids affect my long-term heart health, and is there a plan to taper it safely?
  4. 4.Do my lab results show antiphospholipid antibodies or signs of lupus nephritis, and does this change my cardiovascular risk?
  5. 5.Is my current dose of hydroxychloroquine optimized to help protect my heart?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    Assessment of Arterial Stiffness and Biochemical Markers in Systemic Lupus Erythematosus in the Diagnosis of Subclinical Atherosclerosis.

    Blachut D, Przywara-Chowaniec B, Mazurkiewicz M, Tomasik A

    Journal of personalized medicine 2024; (14(3)) doi:10.3390/jpm14030289.

    PMID: 38541031
  2. 2

    [Case of a Сombination of Lupus Erythematosus, Antiphospholipid Syndrome and Myocardial Infarction].

    Kosheleva NA, Nikitina NM, Andreeva EU

    Kardiologiia 2019; (59(12)):92-96 doi:10.18087/cardio.2019.12.n610.

    PMID: 31849316
  3. 3

    Mortality in patients with systemic lupus erythematosus: A meta-analysis of overall and cause-specific effects.

    Lee YH, Song GG

    Lupus 2024; (33(9)):929-937 doi:10.1177/09612033241257134.

    PMID: 38769901
  4. 4

    Vascular damage in systemic lupus erythematosus.

    Ambler WG, Kaplan MJ

    Nature reviews. Nephrology 2024; (20(4)):251-265 doi:10.1038/s41581-023-00797-8.

    PMID: 38172627
  5. 5

    Crosstalk between Inflammation and Atherosclerosis in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Is There a Common Basis?

    Sircana MC, Erre GL, Castagna F, Manetti R

    Life (Basel, Switzerland) 2024; (14(6)) doi:10.3390/life14060716.

    PMID: 38929699
  6. 6

    Systemic lupus erythematosus and atherosclerosis: immune pathways and the uncharted territory of gut microbiota and metabolism.

    Pan Q, Huang X, Liu C, et al.

    Frontiers in immunology 2025; (16()):1492726 doi:10.3389/fimmu.2025.1492726.

    PMID: 40356907
  7. 7

    Risk factors for cardiovascular diseases in patients with systemic lupus erythematosus: an umbrella review.

    Katayama Y, Yanai R, Itaya T, et al.

    Clinical rheumatology 2023; (42(11)):2931-2941 doi:10.1007/s10067-023-06608-6.

    PMID: 37142864
  8. 8

    Impact of Chronic Glucocorticoid Treatment on Cardiovascular Risk Profile in Patients with Systemic Lupus Erythematosus.

    Moya FB, Pineda Galindo LF, García de la Peña M

    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2016; (22(1)):8-12 doi:10.1097/RHU.0000000000000335.

    PMID: 26693620
  9. 9

    Prevalence and target attainment of traditional cardiovascular risk factors in patients with systemic lupus erythematosus: a cross-sectional study including 3401 individuals from 24 countries.

    Bolla E, Semb AG, Kerola AM, et al.

    The Lancet. Rheumatology 2024; (6(7)):e447-e459 doi:10.1016/S2665-9913(24)00090-0.

    PMID: 38878780
  10. 10

    Impact of antiphospholipid antibodies on cardiac valve lesions in systemic lupus erythematosus: a systematic review and meta-analysis.

    Chen S, Zhou Y, Wang C, et al.

    Clinical and experimental medicine 2024; (24(1)):147 doi:10.1007/s10238-024-01406-z.

    PMID: 38960899
  11. 11

    Hydroxychloroquine increased cholesterol transfer to high-density lipoprotein in systemic lupus erythematosus: A possible mechanism for the reversal of atherosclerosis in the disease.

    Lang MG, Vinagre CG, Bonfa E, et al.

    Lupus 2022; (31(6)):659-665 doi:10.1177/09612033221090127.

    PMID: 35332823
  12. 12

    Association of Higher Hydroxychloroquine Blood Levels With Reduced Thrombosis Risk in Systemic Lupus Erythematosus.

    Petri M, Konig MF, Li J, Goldman DW

    Arthritis & rheumatology (Hoboken, N.J.) 2021; (73(6)):997-1004 doi:10.1002/art.41621.

    PMID: 33403833
  13. 13

    Progression of atherosclerotic plaques over 3 years in patients with systemic lupus erythematosus is inversely associated with continuous hydroxychloroquine treatment.

    Glasin A, Svensson C, Jonasson H, et al.

    Scandinavian journal of rheumatology 2026; (55(1)):10-20 doi:10.1080/03009742.2025.2570588.

    PMID: 41191058
  14. 14

    Cardiovascular disease risk in systemic lupus erythematous: Certainties and controversies.

    Atzeni F, Rodríguez-Pintó I, Cervera R

    Autoimmunity reviews 2024; (23(10)):103646 doi:10.1016/j.autrev.2024.103646.

    PMID: 39321952
  15. 15

    2019 update of the EULAR recommendations for the management of systemic lupus erythematosus.

    Fanouriakis A, Kostopoulou M, Alunno A, et al.

    Annals of the rheumatic diseases 2019; (78(6)):736-745 doi:10.1136/annrheumdis-2019-215089.

    PMID: 30926722
  16. 16

    Role of dyslipidemia in accelerating inflammation, autoimmunity, and atherosclerosis in systemic lupus erythematosus and other autoimmune diseases.

    Wang Y, Yu H, He J

    Discovery medicine 2020; (30(159)):49-56.

    PMID: 33357362

This page provides educational information about cardiovascular risk in lupus. It is not a substitute for professional medical advice; always consult your rheumatologist or cardiologist about your specific heart health.

Get notified when new evidence is published on Systemic lupus erythematosus.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.